位置:首页 > 蛋白库 > V_MEASC
V_MEASC
ID   V_MEASC                 Reviewed;         299 AA.
AC   P0C774;
DT   15-JUN-2010, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 1.
DT   03-AUG-2022, entry version 42.
DE   RecName: Full=Non-structural protein V;
GN   Name=P/V;
OS   Measles virus (strain Ichinose-B95a) (MeV) (Subacute sclerose
OS   panencephalitis virus).
OC   Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina;
OC   Monjiviricetes; Mononegavirales; Paramyxoviridae; Orthoparamyxovirinae;
OC   Morbillivirus.
OX   NCBI_TaxID=645098;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=10949953; DOI=10.1023/a:1008196729676;
RA   Takeuchi K., Miyajima N., Kobune F., Tashiro M.;
RT   "Comparative nucleotide sequence analyses of the entire genomes of B95a
RT   cell-isolated and vero cell-isolated measles viruses from the same
RT   patient.";
RL   Virus Genes 20:253-257(2000).
RN   [2]
RP   FUNCTION.
RX   PubMed=12804771; DOI=10.1016/s0014-5793(03)00528-3;
RA   Takeuchi K., Kadota S.I., Takeda M., Miyajima N., Nagata K.;
RT   "Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-
RT   gamma signaling by inhibiting STAT1 and STAT2 phosphorylation.";
RL   FEBS Lett. 545:177-182(2003).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH HOST STAT2.
RX   PubMed=18579593; DOI=10.1128/jvi.00831-08;
RA   Ramachandran A., Parisien J.P., Horvath C.M.;
RT   "STAT2 is a primary target for measles virus V protein-mediated alpha/beta
RT   interferon signaling inhibition.";
RL   J. Virol. 82:8330-8338(2008).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH HOST IRF7 AND CHUK.
RC   STRAIN=Schwarz vaccine;
RX   PubMed=18922877; DOI=10.1128/jvi.01321-08;
RA   Pfaller C.K., Conzelmann K.K.;
RT   "Measles virus V protein is a decoy substrate for IkappaB kinase alpha and
RT   prevents Toll-like receptor 7/9-mediated interferon induction.";
RL   J. Virol. 82:12365-12373(2008).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH HOST IFIH1 AND DHX58.
RX   PubMed=19403670; DOI=10.1128/jvi.00153-09;
RA   Parisien J.P., Bamming D., Komuro A., Ramachandran A., Rodriguez J.J.,
RA   Barber G., Wojahn R.D., Horvath C.M.;
RT   "A shared interface mediates paramyxovirus interference with antiviral RNA
RT   helicases MDA5 and LGP2.";
RL   J. Virol. 83:7252-7260(2009).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH HOST RELA.
RC   STRAIN=Schwarz vaccine;
RX   PubMed=21270162; DOI=10.1128/jvi.02342-10;
RA   Schuhmann K.M., Pfaller C.K., Conzelmann K.K.;
RT   "The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB
RT   activity.";
RL   J. Virol. 85:3162-3171(2011).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH HOST JAK1 AND TYK2.
RC   STRAIN=Dublin;
RX   PubMed=23431397; DOI=10.1371/journal.pone.0057063;
RA   Chinnakannan S.K., Nanda S.K., Baron M.D.;
RT   "Morbillivirus v proteins exhibit multiple mechanisms to block type 1 and
RT   type 2 interferon signalling pathways.";
RL   PLoS ONE 8:E57063-E57063(2013).
CC   -!- FUNCTION: Plays an essential role in the inhibition of host immune
CC       response. Prevents the establishment of cellular antiviral state by
CC       blocking interferon-alpha/beta (IFN-alpha/beta) production and
CC       signaling pathway. Interacts with host IFIH1/MDA5 and DHX58/LGP2 to
CC       inhibit the transduction pathway involved in the activation of IFN-beta
CC       promoter, thus protecting the virus against cell antiviral state.
CC       Blocks the type I interferon signaling pathway by interacting with host
CC       TYK2 and thereby inhibiting downstream STAT1 and STAT2 phosphorylation.
CC       Moderately affects the type II interferon signaling.
CC       {ECO:0000269|PubMed:12804771, ECO:0000269|PubMed:18579593,
CC       ECO:0000269|PubMed:18922877, ECO:0000269|PubMed:19403670,
CC       ECO:0000269|PubMed:21270162, ECO:0000269|PubMed:23431397}.
CC   -!- SUBUNIT: Interacts with host IFIH1/MDA5 and DHX58/LGP2. Interacts with
CC       host TYK2; this interaction inhibits the type I interferon signaling
CC       pathway without affecting the type II pathway. Interacts with host
CC       IRF7; this interaction inhibits IRF7 translocation to the nucleus.
CC       Interacts with host CHUK and RELA. Interacts (via C-terminus) with host
CC       STAT2. {ECO:0000269|PubMed:18579593, ECO:0000269|PubMed:18922877,
CC       ECO:0000269|PubMed:19403670, ECO:0000269|PubMed:21270162,
CC       ECO:0000269|PubMed:23431397}.
CC   -!- INTERACTION:
CC       P0C774; Q9BYX4: IFIH1; Xeno; NbExp=3; IntAct=EBI-3650423, EBI-6115771;
CC       P0C774; Q04206: RELA; Xeno; NbExp=3; IntAct=EBI-3650423, EBI-73886;
CC       P0C774; P52630: STAT2; Xeno; NbExp=4; IntAct=EBI-3650423, EBI-1546963;
CC   -!- SUBCELLULAR LOCATION: Host cytoplasm {ECO:0000250}.
CC   -!- RNA EDITING: Modified_positions=231; Note=Partially edited. RNA editing
CC       at this position consists of an insertion of one guanine nucleotide.
CC       The sequence displayed here is the V protein, derived from the edited
CC       RNA. The unedited RNA gives rise to the P protein (AC Q9WMB4).;
CC   -!- SIMILARITY: Belongs to the paramyxoviruses V protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB016162; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   SMR; P0C774; -.
DR   DIP; DIP-61740N; -.
DR   IntAct; P0C774; 5.
DR   Proteomes; UP000008699; Genome.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0039564; P:suppression by virus of host JAK-STAT cascade via inhibition of STAT2 activity; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0039554; P:suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of host MDA-5 activity; IEA:UniProtKB-KW.
DR   GO; GO:0039557; P:suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF7 activity; IEA:UniProtKB-KW.
DR   InterPro; IPR024279; Paramyx_V_Zn-bd.
DR   InterPro; IPR028243; Paramyxo_P/V_N.
DR   Pfam; PF13825; Paramyxo_P_V_N; 1.
DR   Pfam; PF13008; zf-Paramyx-P; 1.
PE   1: Evidence at protein level;
KW   Host cytoplasm; Host-virus interaction;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host interferon signaling pathway by virus;
KW   Inhibition of host IRF7 by virus; Inhibition of host MDA5 by virus;
KW   Inhibition of host RLR pathway by virus; Inhibition of host STAT2 by virus;
KW   Interferon antiviral system evasion; Metal-binding; Reference proteome;
KW   RNA editing; Viral immunoevasion; Zinc.
FT   CHAIN           1..299
FT                   /note="Non-structural protein V"
FT                   /id="PRO_0000394721"
FT   REGION          40..94
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          133..168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          204..229
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        142..156
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         232
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         251
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         255
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         267
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         269
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         272
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         276
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         279
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   299 AA;  32016 MW;  FEDBD36B65E382D0 CRC64;
     MAEEQARHVK NGLECIRALK AEPIGSLAVE EAMAAWSEIS DNPGQDRATC KEEEAGSSGL
     SKPCLSAIGS TEGGAPRIRG QGSGESDDDA ETLGIPSRNL QASSTGLQCY HVYDHSGEAV
     KGIQDADSIM VQSGLDGDST LSGGDDESEN SDVDIGEPDT EGYAITDRGS APISMGFRAS
     DVETAEGGEI HELLKLQSRG NNFPKLGKTL NVPPPPNPSR ASTSETPIKK GHRREIGLIW
     NGDRVFIDRW CNPMCSKVTL GTIRARCTCG ECPRVCEQCR TDTGVDTRIW YHNLPEIPE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024